ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko03050	Proteasome	21/340	54/7206	9.63011513475e-15
ko05217	Basal cell carcinoma	16/340	68/7206	6.63043518807e-08
ko05169	Epstein-Barr virus infection	27/340	206/7206	1.14149655485e-06
ko04550	Signaling pathways regulating pluripotency of stem cells	22/340	165/7206	8.71779971207e-06
ko04612	Antigen processing and presentation	14/340	77/7206	1.16315183613e-05
ko03040	Spliceosome	20/340	145/7206	1.34950952568e-05
ko04110	Cell cycle	20/340	145/7206	1.34950952568e-05
ko04390	Hippo signaling pathway	23/340	188/7206	2.28699457205e-05
ko03015	mRNA surveillance pathway	15/340	93/7206	2.55351232769e-05
ko05224	Breast cancer	21/340	174/7206	6.36697934368e-05
ko04340	Hedgehog signaling pathway	11/340	58/7206	6.78556462218e-05
ko00970	Aminoacyl-tRNA biosynthesis	9/340	44/7206	0.000170513739631
ko03030	DNA replication	8/340	38/7206	0.000318765063494
ko04144	Endocytosis	4/340	342/7206	0.000369626932048
ko04921	Oxytocin signaling pathway	1/340	209/7206	0.000734251234285
ko05010	Alzheimer's disease	1/340	202/7206	0.00108502731294
ko03020	RNA polymerase	6/340	29/7206	0.00199243982942
ko04330	Notch signaling pathway	9/340	62/7206	0.00230962667925
ko05205	Proteoglycans in cancer	24/340	271/7206	0.00297122321555
ko04111	Cell cycle - yeast	11/340	90/7206	0.00321937596469
ko04391	Hippo signaling pathway - fly	11/340	90/7206	0.00321937596469
ko04723	Retrograde endocannabinoid signaling	1/340	175/7206	0.0033440119141
ko04310	Wnt signaling pathway	17/340	181/7206	0.00649983005838
ko05166	HTLV-I infection	24/340	292/7206	0.00698390412765
ko05034	Alcoholism	3/340	238/7206	0.00725318379327
ko03410	Base excision repair	6/340	38/7206	0.00810541059868
ko04072	Phospholipase D signaling pathway	2/340	197/7206	0.00920763561376
ko05322	Systemic lupus erythematosus	1/340	151/7206	0.0103310869054
ko04950	Maturity onset diabetes of the young	5/340	29/7206	0.0105825287672
ko04270	Vascular smooth muscle contraction	1/340	154/7206	0.0106532447525
ko05012	Parkinson's disease	1/340	155/7206	0.0108118688774
ko04932	Non-alcoholic fatty liver disease (NAFLD)	2/340	182/7206	0.0124502202153
ko04022	cGMP-PKG signaling pathway	3/340	216/7206	0.0136136451824
ko04024	cAMP signaling pathway	5/340	279/7206	0.0138087793239
ko03013	RNA transport	15/340	166/7206	0.0143378548217
ko03430	Mismatch repair	4/340	22/7206	0.018144226866
ko04726	Serotonergic synapse	1/340	137/7206	0.0222421005211
ko04062	Chemokine signaling pathway	3/340	201/7206	0.0263614316985
ko05418	Fluid shear stress and atherosclerosis	15/340	173/7206	0.0264906871829
ko04350	TGF-beta signaling pathway	10/340	103/7206	0.0296250381612
ko04341	Hedgehog signaling pathway - fly	5/340	38/7206	0.0317131095502
ko04621	NOD-like receptor signaling pathway	2/340	157/7206	0.0347595049452
ko04725	Cholinergic synapse	2/340	160/7206	0.0353334314693
ko04060	Cytokine-cytokine receptor interaction	3/340	191/7206	0.0359755614874
ko05200	Pathways in cancer	33/340	492/7206	0.0360591458334
ko05222	Small cell lung cancer	9/340	89/7206	0.0370747465477
ko04360	Axon guidance	18/340	233/7206	0.0389979609322
ko00240	Pyrimidine metabolism	10/340	110/7206	0.0390055738485
ko04113	Meiosis - yeast	7/340	70/7206	0.0460152323357
ko05206	MicroRNAs in cancer	14/340	177/7206	0.0483924958629
ko01522	Endocrine resistance	11/340	124/7206	0.0489913494992